Clinical Trial Update: SCD Stem Cell Mobilization and Apheresis Using Motixafortide [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Motixafortide to mobilize stem cells and perform apheresis in patients with sickle cell disease, sponsored by St. Jude Childre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Motixafortide (motixafortide)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Sickle Cell Disease | Phase 1 | Status: RECRUITING